[{"address1": "8584 E. Washington Street #127", "city": "Chagrin Falls", "state": "OH", "zip": "44023", "country": "United States", "phone": "213 642 9268", "website": "https://www.novaccessglobal.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D.", "age": 55, "title": "CEO & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 155425, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil J. Laird", "age": 70, "title": "Chief Financial Officer", "yearBorn": 1953, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher  Wheeler Ph.D.", "title": "President of Stemvax Therapeutics", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.0127, "open": 0.0125, "dayLow": 0.0125, "dayHigh": 0.0135, "regularMarketPreviousClose": 0.0127, "regularMarketOpen": 0.0125, "regularMarketDayLow": 0.0125, "regularMarketDayHigh": 0.0135, "beta": 1.508, "volume": 92502, "regularMarketVolume": 92502, "averageVolume": 283530, "averageVolume10days": 281324, "averageDailyVolume10Day": 281324, "marketCap": 373593, "fiftyTwoWeekLow": 0.01, "fiftyTwoWeekHigh": 0.237, "fiftyDayAverage": 0.0218936, "twoHundredDayAverage": 0.0664912, "currency": "USD", "enterpriseValue": 7487746, "floatShares": 12440378, "sharesOutstanding": 27673600, "heldPercentInsiders": 0.58144003, "heldPercentInstitutions": 0.07032, "impliedSharesOutstanding": 26373600, "bookValue": -0.467, "lastFiscalYearEnd": 1696032000, "nextFiscalYearEnd": 1727654400, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -834188, "trailingEps": -0.08, "lastSplitFactor": "1:1000", "lastSplitDate": 1598400000, "52WeekChange": -0.92285717, "SandP52WeekChange": 0.3288405, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "XSNX", "underlyingSymbol": "XSNX", "shortName": "NOVACCESS GLOBAL INC", "longName": "NovAccess Global Inc.", "firstTradeDateEpochUtc": 906384600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "efe54aee-8917-3127-bcfe-6bde48c6bee3", "messageBoardId": "finmb_3184113", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.0135, "recommendationKey": "none", "totalCash": 1505, "totalDebt": 2368544, "currentRatio": 0.003, "returnOnAssets": -36.3589, "freeCashflow": -1960578, "operatingCashflow": -505239, "financialCurrency": "USD", "trailingPegRatio": null}]